Rhino 5 capsules(Spanish & English Labeling), 1 capsule per blister pack, Distributed by P&A Ente...

FDA Recall #D-1045-2014 — Class I — November 18, 2013

Recall #D-1045-2014 Date: November 18, 2013 Classification: Class I Status: Terminated

Product Description

Rhino 5 capsules(Spanish & English Labeling), 1 capsule per blister pack, Distributed by P&A Enterprise, Buena Park, CA 90621, English UPC 6 10708 10730 9, Spanish UPC 6 10708 10729 3.

Reason for Recall

Marketed Without An Approved NDA/ANDA: FDA analysis found Rhino 5 which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug. Dapoxetine is an active ingredient not approved by

Recalling Firm

SS Wholesale Inc. dba Jobbers Wholesale — Paramount, CA

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

2,395 blister packs total for all products

Distribution

CA

Code Information

Lot #: KWAKPMC030505175957019, Exp 12/16

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls